The Role of Early Growth Response 1 (EGR1) in Brain Plasticity and Neuropsychiatric Disorders by Florian Duclot & Mohamed Kabbaj
REVIEW
published: 06 March 2017
doi: 10.3389/fnbeh.2017.00035
The Role of Early Growth Response 1
(EGR1) in Brain Plasticity and
Neuropsychiatric Disorders
Florian Duclot1,2 and Mohamed Kabbaj1,2*
1Department of Biomedical Sciences, Florida State University, Tallahassee, FL, USA, 2Program in Neuroscience, Florida State
University, Tallahassee, FL, USA
Edited by:
Amelia Gallitano,
University of Arizona, USA
Reviewed by:
Clive R. Bramham,
University of Bergen, Norway
Antoine Besnard,
Massachusetts General Hospital,
USA
*Correspondence:
Mohamed Kabbaj
mohamed.kabbaj@med.fsu.edu
Received: 16 December 2016
Accepted: 21 February 2017
Published: 06 March 2017
Citation:
Duclot F and Kabbaj M (2017) The
Role of Early Growth Response 1
(EGR1) in Brain Plasticity and
Neuropsychiatric Disorders.
Front. Behav. Neurosci. 11:35.
doi: 10.3389/fnbeh.2017.00035
It is now clearly established that complex interactions between genes and environment
are involved in multiple aspects of neuropsychiatric disorders, from determining an
individual’s vulnerability to onset, to influencing its response to therapeutic intervention.
In this perspective, it appears crucial to better understand how the organism reacts
to environmental stimuli and provide a coordinated and adapted response. In the
central nervous system, neuronal plasticity and neurotransmission are among the major
processes integrating such complex interactions between genes and environmental
stimuli. In particular, immediate early genes (IEGs) are critical components of these
interactions as they provide the molecular framework for a rapid and dynamic response
to neuronal activity while opening the possibility for a lasting and sustained adaptation
through regulation of the expression of a wide range of genes. As a result, IEGs
have been tightly associated with neuronal activity as well as a variety of higher order
processes within the central nervous system such as learning, memory and sensitivity
to reward. The immediate early gene and transcription factor early growth response 1
(EGR1) has thus been revealed as a major mediator and regulator of synaptic plasticity
and neuronal activity in both physiological and pathological conditions. In this review
article, we will focus on the role of EGR1 in the central nervous system. First, we will
summarize the different factors influencing its activity. Then, we will analyze the amount
of data, including genome-wide, that has emerged in the recent years describing the
wide variety of genes, pathways and biological functions regulated directly or indirectly
by EGR1. We will thus be able to gain better insights into the mechanisms underlying
EGR1’s functions in physiological neuronal activity. Finally, we will discuss and illustrate
the role of EGR1 in pathological states with a particular interest in cognitive functions
and neuropsychiatric disorders.
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INTRODUCTION
Despite a high level of heritability observed in the most common neuropsychiatric disorders, a
clear genetic basis in their etiology has proven difficult to identify (Plomin et al., 1994). Rather,
extensive evidence now indicates that genetic variations among the population markedly influence
one’s vulnerability to develop neuropsychiatric disorders and thus represent major risk factors
(Burmeister et al., 2008; Lee et al., 2013). Indeed, such genetic variations can underlie differences in
the integration of and response to environmental insults that can transpose into deep and lasting
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neuroadaptations responsible for social, emotional and cognitive
impairments characteristics of severe neuropsychiatric disorders
(Caspi and Moffitt, 2006). In this context, it appears critical
to better understand the molecular processes and mechanisms
underlying such gene× environment interactions.
In the central nervous system, immediate early genes (IEGs)
are critical mediators of gene × environment interactions and
thus have been the focus of an extensive research interest in
order to elucidate how environmental stimuli trigger a fast
response with enduring neuroadaptations on neuronal activity
and plasticity (Herdegen and Leah, 1998; Bahrami and Drabløs,
2016). Indeed, the defining characteristic of IEGs is the rapid and
transient up-regulation—within minutes—of their mRNA levels
independent of protein synthesis. Furthermore, this regulation
can be triggered by a wide variety of stimuli through activation
of general intracellular signaling pathways such as the mitogen-
activated protein kinases (MAPK) or phosphoinositide 3-kinase
(PI3K) pathways (Beckmann and Wilce, 1997; Fowler et al.,
2011; Bahrami and Drabløs, 2016). Combined with the fact
that many IEGs act as transcription factors, these features
allow for a rapid and dynamic response to neuronal activity,
followed by a second wave of transcriptional regulation likely
to encode enduring adaptations at the synaptic and neuronal
levels. Unsurprisingly, IEGs involvement in neuronal functions
is widespread. In addition to representing key elements in
understanding neuronal activity and physiological response to
environmental stimuli, deciphering IEGs functions can provide
a wealth of information on how these mechanisms are impaired
in pathological conditions and thus bring novel insights into
the molecular mechanisms underlying severe neuropsychiatric
disorders.
Despite their widespread nature and overlap, each IEG
differs in activators, upstream regulatory pathways, targets and
expression pattern (Beckmann and Wilce, 1997; Herdegen and
Leah, 1998; O’Donovan et al., 1999; Poirier et al., 2008; Bahrami
and Drabløs, 2016). As such, early growth response 1 (EGR1)
represents a particularly interesting IEG in the context of
neuropsychiatric disorders due to its involvement in critical
processes underlying neuronal activity, from neurotransmission
and synaptic plasticity, to higher order processes such as learning
and memory, response to emotional stress and reward. In this
review aticle, we will thus focus on the role of EGR1 in the
central nervous system in both physiological and pathological
conditions. We will first briefly summarize the different factors
regulating EGR1 expression, and then take advantage of recent
genome-wide transcriptomic data to analyze the genes, pathways,
and biological functions targeted by EGR1 in the central nervous
system. Finally, we will discuss and illustrate the role of
EGR1 in pathological states with a particular interest in cognitive
functions and neuropsychiatric disorders.
FUNCTIONS AND REGULATIONS OF EGR1
Structure and Expression Pattern
EGR1 was first discovered and cloned almost three decades
ago during a screening of genes rapidly up-regulated by nerve
growth factor (NGF) in the rat PC12 cells in the presence of
the protein synthesis inhibitor cyclohexamide (Milbrandt, 1987),
thereby meeting criteria for an IEG. The same protein was cloned
and described simultaneously by different groups in multiple
cell lines stimulated by various growth factors, which explains
the existence of several alternate names: EGR1 (Sukhatme et al.,
1988), NGFI-A (Milbrandt, 1987), Krox-24 (Lemaire et al., 1988),
TIS8 (Lim et al., 1987, 1989), and Zif268 (Christy et al., 1988).
Notably, similar screening strategies led to the identification of
EGR2, EGR3 and EGR4, which alongside EGR1 constitute the
EGR family of IEGs (Beckmann and Wilce, 1997; O’Donovan
et al., 1999).
The structural similarities and differences between all four
EGR proteins have been described in details and summarized
elsewhere (Beckmann and Wilce, 1997) and thus will not be
extensively detailed in the current review article. Nevertheless,
it is important to note that all four members of the EGR
family are highly homologous both within and between species
around a region containing three Cysteine2-Histidine2 (C2H2)
zinc fingers DNA-binding domains, suggesting similarities in
the DNA sequences recognized by each EGR protein and
thus the possibility of overlap in their respective targets and
functions (Figure 1). Similarly, EGR1, EGR2 and EGR3, but not
EGR4, exhibit a domain of interaction with the transcriptional
co-repressors NGFI-A-1/2 (NAB1 and NAB2) that, in addition
to providing a negative control on the transcriptional activity
of EGR proteins (Gashler et al., 1993; Russo et al., 1993,
1995; Svaren et al., 1996; Beckmann and Wilce, 1997), suggests
that EGR1, EGR2 and EGR3 can lead to transcriptional
repression—a role supported in part by experimental evidence
in vivo (James et al., 2005, 2006; Duclot and Kabbaj, 2015).
Interestingly, aligning the amino-acids sequences for all EGR
proteins from humans, rats and mice, reveals that differences
between EGR proteins are greater within species than between
species, suggesting that similarities and specificities of each EGR
member are evolutionary conserved. Despite this homology,
however, the N-terminal region differs substantially between
all four members of the EGR family, indicating specificities in
protein-protein interactions and thus differences in regulation,
reactivity, transcriptional control, and ultimately neuronal
function (O’Donovan et al., 1999; Poirier et al., 2008).
In line with functional differences between members of
the EGR family, the constitutive EGR2 knock-out is lethal
whereas mice lacking EGR1 are viable despite reduced body
size, sterility associated with alterations of the pituitary-gonadal
axis, as well as axial myopia (Lee et al., 1995; Beckmann
and Wilce, 1997; Topilko et al., 1998; Schippert et al., 2007),
which indicates that EGR1 is not critically involved in prenatal
development. Accordingly, EGR1 expression is undetectable in
the embryonic nervous system (McMahon et al., 1990; Crosby
et al., 1992), but slowly rises throughout postnatal development
to reach adult expression levels by postnatal day 17 in the
rat hippocampus, for instance (Watson and Milbrandt, 1990;
Herms et al., 1994; Beckmann and Wilce, 1997). Interestingly,
this progressive increase in EGR1 expression parallels the time
of synaptic formation in cortical regions, and in the hippocampal
CA1 area, corresponds closely to the period of maximal response
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FIGURE 1 | Schematic representation of human early growth response 1 (EGR1) protein. The three zinc fingers domains of the human EGR1 protein (Uniprot
#P18146) are depicted with black bars, alongside the main post-translational modification sites identified so far (P, Phosphorylation; SUMO, Sumoylation; S, Serine;
T, Threonine). The T309 and S350 sites are phosphorylated by AKT (Yu et al., 2009), whereas S378, T391 and T526 represent the main sites phosphorylated by
casein kinase 2 (CSNK2; Jain et al., 1996).
to N-methyl-D-aspartate (NMDA) and long-term potentiation
(LTP) inducibility (Herms et al., 1994), which underscores the
relationship between EGR1 expression and synaptic plasticity.
In adulthood, EGR1 is expressed widely throughout the brain,
and thus maintains baseline expression levels in several key areas
for control of cognition, emotional response, social behavior
and sensitivity to reward such as the medial prefrontal cortex
(mPFC), striatum, hippocampus and amygdala (Herdegen et al.,
1995; Beckmann and Wilce, 1997; Knapska and Kaczmarek,
2004).
Upstream Regulators
Signaling Pathways and Transcriptional Control
Following the original discovery of EGR1 induction following
PC12 cells stimulation by NGF (Milbrandt, 1987), its expression
levels were quickly linked to synaptic activity in mature
neurons. In particular, in vivo electrical stimulations inducing
long-term potentiation (LTP) also up-regulate Egr1 mRNA
levels in an NMDA receptor-dependent manner (Cole et al.,
1989; Wisden et al., 1990). Similarly, Egr1 mRNA levels rapidly
and transiently increase in the rat forebrain, cerebellum and
hippocampus following pharmacological induction of seizures
(Saffen et al., 1988). Since then, the range of stimulations
able to induce Egr1 mRNA up-regulation has greatly expanded
and includes a variety of factors linked to neurotransmission
and synaptic activity. These include neurotransmitters such as
glutamate and dopamine, their receptors such as NMDA or
dopamine D1 receptors, as well as their respective agonists
or cellular depolarization itself (Beckmann and Wilce, 1997;
Herdegen and Leah, 1998; Knapska and Kaczmarek, 2004).
In line with these extracellular signals, multiple intracellular
signaling pathways downstream of these receptors directly
regulate EGR1 expression. Similar to other IEGs (Bahrami and
Drabløs, 2016), the RhoA-actin (Mullin et al., 2007), extracellular
signal-regulated kinase (ERK; Sgambato et al., 1998; Davis
et al., 2000) and p38 (Lim et al., 1998; Rolli-Derkinderen
et al., 2003) MAPK, or PI3K (Kumahara et al., 1999) have
been reported to control EGR1 expression in various systems,
including neurons in vivo (Beckmann and Wilce, 1997; Herdegen
and Leah, 1998; Knapska and Kaczmarek, 2004). Altogether,
these observations would indicate that EGR1 expression can
be activated upon a wide variety of stimuli, as reflected by
its up-regulation following an intracellular calcium increase
in hippocampal neurons (Bading et al., 1995), and support
the notion that EGR1 is generally activated upon neuronal
activity (Figure 2). While such a wide range of stimulating
factors can represent a challenge in pinpointing the exact
role of EGR1 in synaptic activity, this feature can be turned
into an advantage by using EGR1 expression as a marker of
neuronal activity allowing to map brain activation following
a specific behavioral, pharmacological, or environmental event
(Farivar et al., 2004; Stack et al., 2010; Okuno, 2011; Hollis
et al., 2012; Duclot et al., 2016). Interestingly, EGR1’s induction
following neuronal activity could also prove useful in tagging
neurons activated by specific stimuli which, coupled with
optogenetics, for instance, offers interesting methods to study the
functions of neuronal ensembles in high order brain functions
(Ramirez et al., 2015; Tonegawa et al., 2015). In this context,
it is particularly interesting to note that Egr1 promoter can
successfully be used in a reporter construct (Tsai et al., 2000).
Combined with the specific roles of EGR1 in regulating neuronal
plasticity (see ‘‘EGR1 Role in Pathological States’’ Section),
this provides unique opportunities to investigate the neuronal
ensembles underlying anxiety, stress response, and stress-related
disorders.
Upon activation, these intracellular signaling pathways will
engage their respective final effector(s) and transcription
factor(s) to directly regulate Egr1 gene transcription. Induction
of the p38 and ERK MAPK pathways, for instance, leads to
activation of the Ets-like-1 (Elk1) and cyclic AMP-response
element binding protein (CREB) transcription factors, which
can bind their respective response elements located in the
Egr1 promoter (Tur et al., 2010). In addition to these serum
response elements (SRE) and cAMP response element (CRE),
several other binding sites for key transcription factors were
identified on the Egr1 promoter: specificity protein 1 (Sp1),
activator protein-1 (AP-1), nuclear factor kappa B (NFκB),
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FIGURE 2 | Model for EGR1 regulations and functions in the central nervous system in the context of synaptic plasticity. In response to various stimuli
such as stress or learning tasks triggering growth factors release, hormones secretion, or neuronal activity, several intracellular signaling pathway including
mitogen-activated protein kinases (MAPK) or AKT are activated. Transcription factors such as serum response factor (SRF), cyclic AMP-response element binding
protein (CREB), or Ets-like-1 (ELK1), are thus induced and rapidly regulate Egr1 transcription. EGR1 can in turn directly regulate a wide array of transcriptional targets
related to multiple biological functions related to synaptic plasticity: vesicular release and endocytosis, neurotransmitters metabolism, micro-RNA (miRNA), receptors,
signaling pathways, actin cytoskeleton, as well as component of the proteasome complex. A few validated EGR1 targets are depicted under each biological
functions. Through such a wide array of direct transcriptional targets, EGR1 can thus regulate multiple aspects of synaptic plasticity, and thus orchestrate the
integration of environmental stimuli at the synaptic plasticity level to modulate relevant high order processes such as learning and memory, addiction, anxiety, and
neuropsychiatric disorders. Finally, several negative feedback mechanisms are also engaged, either directly through EGR1 itself, or indirectly through its direct targets
such as NAB1 or miR-124. Arc, activity-regulated cytoskeleton-associated protein; Chrna7, cholinergic receptor nicotinic alpha 7 subunit; ERK1/2, extracellular
signal-regulated kinase (ERK)s 1/2; Gad1, glutamate decarboxylase 1; Gr, Glucocorticoids receptor; Grin1, glutamate ionotropic receptor N-methyl-D-aspartate
(NMDA) type subunit 1, JNK, Jun N-terminal kinase; Mapk1, mitogen activated protein kinase 1; NAB1, NGFI-A-1; PSD-95, Postsynaptic density protein 95;
Snap29, synaptosomal-associated protein 29; Snap91, synaptosomal-associated protein 91; Stx6, syntaxin 6.
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or EGR1 itself (Knapska and Kaczmarek, 2004; Tur et al.,
2010). While most of these factors are generally considered
as positive regulators of transcription, this view is challenged
by the bivalent role of Elk1, for instance, either promoting
transcription through recruitment of histone acetyltransferases
(Li et al., 2003), or repressing transcription through recruitment
of histone deacetylases (HDAC; Yang et al., 2001). Similarly,
EGR1 binding to its own promoter represses its transcription
(Cao et al., 1993).
The complexity of Egr1 transcriptional regulation can be
resolved, however, when accounting for kinetics and interactions
between transcription factor binding, cofactors recruitment
and chromatin dynamics including histone methylation,
acetylation and phosphorylation, as well as nucleosome
positioning. Indeed, by focusing on Egr1 gene transcription
in MLP29 mouse progenitor cells, Riffo-Campos et al. (2015)
propose a model in which Elk1, CREB and EGR1 interact in
a timely manner to allow for a quick and transient activation
of Egr1 transcription. Following application of phorbol esters
in this system, EGR1 expression is induced within minutes,
peaks at 30 min post-application, and returns to baseline levels
by 180 min (Tur et al., 2010; Riffo-Campos et al., 2015). Prior
to treatment with phorbol esters, three components of HDAC
complexes, mSin3, HDAC3 and N-CoR are present on the Egr1
promoter (Tur et al., 2010). Interestingly, however, CREB, Elk1,
SRF and RNA-PolII are also found at the promoter even prior
to its induction, explained in part by a favorable nucleosome
positioning (Riffo-Campos et al., 2015), which thus suggests
that, similar to other IEGs (Bahrami and Drabløs, 2016), Egr1
transcription is poised at baseline. Induction by phorbol esters,
however, triggers characteristic nucleosome repositioning
events with partial eviction of the +1 and −1 nucleosomes,
as well as downstream sliding of the −2 nucleosome at the
15 min timepoint. At the same time, Egr1-promoter bound
CREB and Elk1 are phosphorylated in a p38- and MEK1/2-
dependent manner (Tur et al., 2010), resulting in an increase
in phosphoacetylation (pS10AcK14) and acetylation (AcK14)
of histone H3 at the +1 nucleosome (Riffo-Campos et al.,
2015). Such acetylation events are likely mediated by the
histone acetyltransferase activity of the transcriptional cofactor
CREB-binding protein (CBP) as its binding to the mouse Egr1
promoter increases in parallel with its transcription (Tur et al.,
2010). As a result, RNA-PolII recruitment rises and promotes
Egr1 transcription in a rapid manner. Simultaneously, however,
the downstream sliding of the −2 nucleosome partly uncovers
an EGR1 recognition site located slightly upstream and thus
allows EGR1 binding to its own promoter (Riffo-Campos et al.,
2015), which in turn leads to the progressive recruitment of
the transcriptional repressors NAB1 and NAB2 peaking from
30 min–60 min following induction (Tur et al., 2010). As
NAB2 is known to interact with the nucleosome remodeling and
deacetylase complex (NuRD; Srinivasan et al., 2006), it is likely
that this interaction is responsible for the progressive decline in
histone acetylation and phosphoacetylation, as well as the return
of nucleosomes to baseline positions leading to reduction in
EGR1 expression (Tur et al., 2010; Riffo-Campos et al., 2015).
Interestingly, NAB2 is not constitutively expressed but induced
by factors such as EGR1, which does provide a negative feedback
loop mechanism for EGR1 expression allowing to explain the
transient nature of its expression.
Epigenetics, Post-Translational Modifications and
Other Regulators
Importantly, such regulations of Egr1 transcription by histone
acetylation and methylation events are also found in neurons
in vivo as part of neuroadaptations underlying learning and
memory, cognitive functions and response to stress (Gräff et al.,
2012; Xie et al., 2013; Hendrickx et al., 2014; Rusconi et al.,
2016). Furthermore, DNA methylation and hydroxymethylation
have also been linked to the control of Egr1 transcription
associated with environmental impact on synaptic transmission
upon aging in the rat hippocampus (Penner et al., 2016), or sleep
deprivation in the mouse cortex (Massart et al., 2014). Altogether,
it is therefore clear that epigenetic mechanisms are not only
an essential part of Egr1 regulation, but also key mediators of
neuroadaptations critical to physiological and pathological brain
functions.
Furthermore, EGR1 levels can be regulated on another
epigenetic layer through micro-RNA (miRNA). Indeed, in
peripheral tissues and several cancer cell lines, several studies
report direct targeting of EGR1 by miR-543 (Zhu et al., 2016),
miR-192 (Wu et al., 2016), miR-146a (Contreras et al., 2015),
miR-7578 (Zhang et al., 2013), miR-183 (Sarver et al., 2010),
or miR-124 (Liu et al., 2016; Wang et al., 2016). Interestingly,
the latter is highly expressed in the brain and is a critical
regulator of neuronal function and thus an important mediator
of neuroadaptations in response to chronic stress, reward and
learning and memory (Sun et al., 2015). In line with the
involvement of EGR1 in these processes as well, a regulation of
EGR1 levels by miR-124 has also been reported in the central
nervous system. Indeed, miR-124 knockdown in the mouse
mPFC and hippocampus increase EGR1 mRNA and protein
levels, reflected by improvements in spatial learning and social
behaviors impaired in exchange protein directly activated by
cyclic AMP (EPAC)-knockout (KO) mice (Yang et al., 2012).
Interestingly, although no effect on synaptic transmission was
observed, this effect was associated with complete restoration
of LTP that was previously abolished in EPAC-KO mice (Yang
et al., 2012), which thus indicates that EGR1-targeting miRNA
are likely to be involved in the numerous functions under control
of EGR1.
In addition to such epigenetic mechanisms,
EGR1 transcriptional activity or stability can also be dynamically
regulated through post-translational modifications (Figure 1)
including phosphorylation, acetylation, sumoylation and
ubiquitination (Beckmann and Wilce, 1997; Veyrac et al.,
2014). For instance, while EGR1 phosphorylation levels
are very low in unstimulated cells, EGR1 proteins induced
by growth factors or UV radiations undergo substantial
phosphorylation events—involving in part protein kinase C or
tyrosine kinases—resulting in an increase in its DNA binding
activity (Cao et al., 1992, 1993; Huang et al., 1998). Similarly,
EGR1 can be acetylated by the histone acetyltransferase
complex p300/CBP, which reduces its transcriptional activity
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(Yu et al., 2004). Interestingly, EGR1 can undergo sumoylation
and ubiquitination, and has been reported to interact directly
with proteasome component C8, describing a likely mechanism
controlling its targeting for proteolysis by the ubiquitin-
dependent proteasome pathway (Bae et al., 2002; Li et al.,
2015). Notably, such regulation has been observed following
stimulation of ECV304 cells by epidermal growth factor,
which increases sumoylation and ubiquitination levels of
endogenous EGR1 proteins, ultimately leading to higher
EGR1 turnover through proteasome-mediated degradation
(Manente et al., 2011). Altogether, these observations suggest
that post-translational modifications are critical regulators of
EGR1 activity and stability. As further illustration, a detailed
mechanistic work describes a signaling pathway in which
EGR1 is phosphorylated at the T309 and S350 residues by Akt
in response to insulin-like growth factor 1, thereby enhancing its
interaction with alternate reading frame (ARF) which mediates
sumoylation of EGR1 at the K272 residue and activation of
the protein phosphatase and tensin homolog (PTEN; Yu et al.,
2009). As such modifications can be observed in the brain
following cocaine exposure, for instance (Xu and Kang, 2014),
post-translational modifications thus represent a critical level
in the regulation of EGR1 functions in the central nervous
system.
Finally, it is important to note that EGR1 expression differs
between strains (Pollak et al., 2005) and sexes in the central
nervous system, in a structure-specific manner. Indeed, adult
female rats exhibit lower EGR1 mRNA and protein levels than
males in the mPFC, but not in the striatum, or hippocampal
CA1 area (Stack et al., 2010; Duclot and Kabbaj, 2015; Yagi
et al., 2016). Interestingly, the sex bias is opposite in the
dorsal CA3 area, where the density of EGR1-expressing cells
is higher in female rats than males (Yagi et al., 2016). A
possibility to explain such sex differences in EGR1 expression
could reside in the ovarian hormone estrogen, as the latter can
directly up-regulate EGR1 expression. In the mouse mammary
gland, for instance, EGR1 is at the center of a gene regulation
network triggered by exposure to estrogen (Lu et al., 2008),
while its mRNA levels in the mouse uterus are up-regulated
following estrogen treatment (Kim et al., 2014). Surprisingly,
although an estrogen response element (ERE) has been identified
on the Egr1 promoter, the induction of Egr1 transcription
by estrogen is mediated by SRF and Elk1 binding to SRE
rather than binding of estrogen receptors to their ERE, and
is blocked by a MAPK but not PI3K pathway inhibitor
in rat cardiomyocytes or MCF-7 human breast cancer cells
(Slade and Carter, 2000; Chen et al., 2004), indicating that
EGR1 is a downstream target of estrogen’s non-genomic effects.
Interestingly, treatment with progesterone either doesn’t affect
Egr1 mRNA (Lu et al., 2008), or dampens the estrogen-induced
up-regulation of Egr1 mRNA in the mouse uterus (Kim et al.,
2014), which suggests that ovarian hormones can interact to
regulate EGR1 expression. These interactions are likely to be
specific to neurons, however, as Egr1, among other IEGs, is
strongly up-regulated in Schwann cells following progesterone
treatment (Mercier et al., 2001). Accordingly, we recently found
that Egr1 mRNA levels in the rat mPFC vary across the estrous
cycle with lower levels in the early afternoon of proestrus than
in diestrus (Duclot and Kabbaj, 2015), which therefore opens
the possibility that genes and biological pathways under direct
control of EGR1 also differ between sexes in an estrous cycle-
dependent manner.
Downstream Targets
Inherent from the characteristic features of an IEG, EGR1 is
rapidly up-regulated in neurons following neuronal activity and
orchestrates a subsequent wave of gene regulation to allow
for the long-term and enduring encoding of the neuronal
information. Surprisingly, despite its well-known association
with several processes of neuronal and synaptic plasticity, the
precise mechanisms by which EGR1 influences these processes
remains unclear. In particular, relatively little is known as to its
exact transcriptional targets and gene expression profile under its
control, especially in a neuronal context.
From its original cloning nearly three decades ago and
the description of three zinc fingers binding domains, the
9-nucleotide long sequence GCGG/TGGGCG was defined as
the EGR1 recognition sequence (Christy and Nathans, 1989;
Pavletich and Pabo, 1991). The presence of this specific EGR
response element could thus theoretically be a good indicator
of a direct transcriptional control by EGR1. Nevertheless, a
more detailed analysis of EGR1 binding sequence revealed
variation in this sequence and identified an optimal site of at
least 10 nucleotides rather than 9 (Swirnoff and Milbrandt,
1995). Moreover, experimental evidence indicates that EGR1 can
also regulate gene expression through interaction with other
transcription factors such as c/EBPβ, Fos, or Jun (Levkovitz and
Baraban, 2002; Zhang et al., 2003; Knapska and Kaczmarek, 2004;
Cheval et al., 2012), which thus further expands the range of
potential EGR1 targets and related biological pathways under its
control.
The investigation of EGR1 targets was first conducted on
a single-gene basis, through the focus on a particular cellular
regulation in a given system. Although this approach led to
the identification of numerous EGR1 target genes (Beckmann
and Wilce, 1997; Herdegen and Leah, 1998; Knapska and
Kaczmarek, 2004), the vast majority of EGR1 potential targets
remained to be deciphered. In the early 2000s, the popularization
of genome-wide techniques opened the possibility to search
for EGR1-regulated genes on a large scale. In several prostate
carcinoma cell lines, in which EGR1 is found overexpressed,
endogenous or adenovirus-mediated overexpression of
EGR1 impacts the expression of multiple genes, including
several growth factors such as insulin-like growth factor II (Igf2),
platelet-derived growth factor-A (PDGF-A), and transforming
growth factor-β1 (TGF-β), as well as membrane-associated
proteins, transcription factors and cofactors, all strengthening
the involvement of EGR1 in response to growth factors,
tumor progression, and apoptosis in these systems (Svaren
et al., 2000; Virolle et al., 2003; Arora et al., 2008). Notably,
the largest gene class identified in the prostate carcinoma
cell lines following EGR1 overexpression includes several
neuroendocrine-related genes found highly expressed in the
central nervous system (Svaren et al., 2000), which pinpoints a
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direct control of neuron-specific genes by EGR1. It is important
to note, however, that these regulations are in part cell-specific
as similar microarray analyses in human endothelial cells
overexpressing EGR1 revealed a different gene regulation profile
despite common targets such as TGF-β, Igf2, and p57kip2 (Fu
et al., 2003). Furthermore, a recent investigation of miRNA
directly regulated by EGR1 in the human erythroleukemia
cell line K562 reported a total of 124 distinct miRNA and
63 pre-miRNA bound by EGR1 following stimulation by
phorbol ester—which activates EGR1 expression in this cell
line (Wang et al., 2010). One of these miRNA, miR-124, is of
particular interest as it is a known regulator of EGR1 levels
(Liu et al., 2016; Wang et al., 2016), including in the central
nervous system (Yang et al., 2012), and is tightly associated
with neuronal function and higher order processes (Sun et al.,
2015). Therefore, in addition to represent a likely mediator
in EGR1 control of neuronal activity, these observations
suggest that miR-124 could be involved in a negative feedback
loop controlling EGR1 expression at the post-transcriptional
level.
In order to better characterize how EGR1 binds to its
target genes to regulate their transcription, and in an effort
to better predict the potential direct EGR1 targets, several
studies have investigated EGR1 binding through chromatin
immunoprecipitation (ChIP) following by microarray profiling
in monocytic differentiation of human monoblastoma cells or
following UV-induced apoptosis in prostate carcinoma cells
(Arora et al., 2008; Kubosaki et al., 2009). While these studies
provide rich information regarding their specific systems, a more
comprehensive understanding of EGR1 binding can be drawn
from the effort of the Encyclopedia of DNA Elements (ENCODE)
project. Indeed, as the ENCODE project included EGR1 as
part of the tier 1 chromatin immunoprecipitation followed by
deep sequencing (ChIP-seq), a wealth of information regarding
EGR1 DNA binding characteristics and target genes has
been made available (ENCODE Project Consortium, 2012). In
particular, we are thus able to analyze and compare the binding
pattern of 161 transcription factors across 91 cell types and a total
of 4,380,444 genomic regions, among which 44,985 correspond
to an EGR1 binding event. Out of the 15,872 genes thus
annotated, 8552 (53.9%) contain at least one EGR1 binding
region (peak) within 3 kb of their transcription start site (TSS),
which indicates that across several human cell types, EGR1 can
bind a very large number of genes and thus potentially regulate
a very large gene expression profile (see full annotated list in
Supplementary Table S1). As previously reported, EGR1 binds
in close vicinity to the TSS (Project Kubosaki et al., 2009;
ENCODE Project Consortium, 2012), but even though 41.6% of
all EGR1 peaks are located within the promoter region, 26.4%
are located within intronic regions. Notably, in line with the high
GC content in the EGR1 consensus binding sequence, 31% of all
annotated EGR1 peaks are located within a known CpG island,
as previously reported by ChIP-chip promoter array analysis
in human monoblastoma cells under monocytic differentiation
(Kubosaki et al., 2009). Pending further analysis of CpG island
and DNA methylation, the presence of a CpG island would thus
appear to be a useful informative feature refining the prediction
of putative EGR1 binding to a given gene across a variety of cell
types.
The functional analysis of genes with at least one EGR1 peak
from the ENCODE dataset reveals the enrichment of pathways
and processes related to growth factors signaling, including
neurotrophins, as well as general intracellular signaling cascades
such as Ras or MAPK, which also controls EGR1 expression itself
(Figure 3, and ‘‘Upstream Regulators’’ Section). Interestingly,
the molecular functions of EGR1-bound genes range from
chromatin and transcription factors activity to guanyl-nucleotide
exchange factor activity through serine/threonine kinase activity
(Figure 3D), which therefore indicates that EGR1 exerts a
transcriptional control on every level of signal transduction
cascade, from second messenger to transcription factor.
Accordingly, the cellular localization of the EGR1-bound genes’
products range from the chromatin to the cell membrane
(Figure 3C). It is important to note, however, that the latter
encompasses the top enrichment hits, and reflects an enrichment
of a large number of processes and pathways related to cell-cell
recognition and interactions, observed across all enrichment
domains (Figure 3), which suggests that EGR1 is likely to regulate
cell-cell communication through a wide number of genes.
Although this observation emerges from non-neuronal cell types
(ENCODE Project Consortium, 2012), similar observations were
made in the mouse brain. Indeed, following EGR1 ChIP-seq
in the mouse cortex, a total of 11,103 genes were found bound
by EGR1 in close vicinity to their TSS and were enriched for
biological processes and pathways related to protein trafficking,
synaptic vesicles transport, endocytosis, protein phosphorylation
and intracellular signaling cascades (Koldamova et al., 2014). In
this context, the relations of EGR1-bound genes with multiple
levels of cell-cell communication, from reorganization of the
actin cytoskeleton, to transcription factors through intracellular
signaling cascades grant EGR1 the ability to control neuronal
activity in a widespread manner.
In addition to the biological functions described above,
a distinct pattern associated with EGR1-bound genes relates
to proteasome-mediated and ubiquitin-dependent protein
degradation, found in all annotation domains analyzed
(Figure 3). Interestingly, while the regulation of growth
factors signaling and transcription factors-related processes
were observed in genes bound by EGR1 in their promoter
or intronic regions, the enrichment of proteasome-mediated
degradation processes preferentially involves genes bound
by EGR1 in intronic regions (Figure 3B). Although its
functional significance remains unknown, this may indicate
that EGR1 control of proteasomal degradation-related
genes is mediated through binding to enhancer regions or
alternative TSS. Most importantly, such link between EGR1 and
proteasome-mediated protein degradation is also found in
neurons, as viral overexpression of EGR1 in cultured neuronal
PC12 cells affects the expression of 135 genes, enriched for
components of the proteasome and ubiquitin-related factors
(James et al., 2005). Similarly, transgenic overexpression of
EGR1 in the mouse forebrain results, in the amygdala, in the
up-regulation of proteins related to the proteasome-core
complex, among other processes such as metabolism,
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FIGURE 3 | Functional analysis of EGR1 targets from the encyclopedia
of dna elements (ENCODE) datasets. All genes annotated near an
EGR1 peak (“All_genes”), or those with at least one EGR1 peak called within
their promoter region (3 kb around transcription start site (TSS),
“Prom_genes”), or within their intronic region (“Intron_genes”), were
functionally annotated with the Kyoto Encyclopedia of Genes and Genomes
(KEGG) database (A) and the gene ontology database distinguishing between
the biological processes (B) cellular component (C) and molecular functions
(D) domains with the Bioconductor package ChIPSeeker (v1.8.9; Yu et al.,
2015).
phosphorylation, or metal ion transport (Baumgärtel et al.,
2009). Given that these regulations were also associated with
genes involved in intracellular signaling, synapse formation and
architecture, as well as neurotransmitter release, it is tempting
to conclude that EGR1 is a master regulator of neuronal
activity at multiple level of the synaptic and neuronal plasticity
processes by orchestrating a widespread gene expression profile
(Figures 2, 3).
It is important to keep in mind, however, that although
the majority of genes affected by EGR1 overexpression
present with one or more predicted EGR response elements
(James et al., 2005; Baumgärtel et al., 2009), the absence of
direct measurement of EGR1 binding and the possibility of
detecting extra-physiological EGR1 transcriptional activity due
to exogenous overexpression cannot be ruled out. Recently,
however, we took advantage of endogenous differences in
EGR1 expression levels in the rat mPFC between males and
females, as well as within females across the estrous cycle,
to provide additional in vivo ChIP-seq information on its
direct targets underlying its role in neuronal activity. We
thus found that between proestrus and diestrus females, the
transcriptomic changes were very large and paralleled by
widespread differential binding of EGR1 throughout the genome
(Duclot and Kabbaj, 2015). Supporting James et al. (2005)
findings in cultured neuronal cells, the EGR1-bound genes
were highly enriched for biological processes related to synaptic
function—neurotransmitters, signal transduction, presynaptic
vesicular trafficking, synapse formation and assembly, and
protein translation and degradation (Duclot and Kabbaj, 2015).
Notably, this enrichment was even stronger when considering
only the genes detected by RNA-seq as differentially expressed,
which strongly suggests that EGR1-binding to these genes was
transcriptionally effective.
EGR1 ROLE IN SYNAPTIC PLASTICITY
Following the original report of Egr1 mRNA levels increase
by NGF (Milbrandt, 1987), stimulation of neuronal activity
was soon identified as a potent trigger for EGR1 induction.
In particular, high, but not low, frequency stimulation of the
perforant path, which induces LTP, increased Egr1 mRNA
levels in the ipsilateral granule cell neurons (Cole et al., 1989).
Importantly, NMDA receptors antagonism or simultaneous
synaptic inputs inhibiting LTP were able to block this response,
and thereby were the first demonstration that EGR1 expression
can be induced by conditions favorable to LTP formation. At
the molecular level, this EGR1 regulation requires the MAPK
MEK and triggers the ERK1/2, Elk1 and CREB signaling cascade
(Davis et al., 2000; Veyrac et al., 2014). Interestingly, early
correlations between EGR1 levels and LTP expression pointed
towards a link between EGR1 and LTP persistence, rather than
its induction (Richardson et al., 1992; Abraham et al., 1993;
Knapska and Kaczmarek, 2004). This was confirmed later in
EGR1-KO mice in which early hippocampal LTP was intact,
but was not present 24–48 h post-tetanic stimulation while,
indicating that EGR1 is required specifically for the maintenance
of LTP, but not its induction (Jones et al., 2001). Conversely,
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EGR1 overexpression in the forebrain enhances LTP in the
mouse dentate gyrus (Penke et al., 2014). As hippocampal LTP
is considered a molecular hallmark of spatial memory formation
(Sweatt, 2016), the role of EGR1 in learning and memory
paradigms has been extensively studied and recently reviewed
elsewhere (Bozon et al., 2002; Knapska and Kaczmarek, 2004;
Veyrac et al., 2014). This will thus not be discussed in detail
here.
It is important to note, however, that in line with the
important role of EGR1 in late-phase LTP, short-term spatial
memory is intact in EGR1-KO mice, while spatial long-term
memory is impaired (Jones et al., 2001), suggesting a critical
role for EGR1 in memory consolidation. Although EGR1 is
up-regulated following a wide range of learning procedures,
this effect remains structure-specific and is generally observed
in the brain regions relevant to the nature of the learning
task (Veyrac et al., 2014), in line with its induction by
neuronal activity. Moreover, the functional and behavioral
outcome of EGR1 up-regulation in learning in memory is
also specific to the nature of the task. For instance, although
EGR1 knockdown by RNA interference in the amygdala
impairs the consolidation of cued and contextual fear memory,
EGR1 knockdown in the hippocampus impairs contextual
memory reconsolidation but not consolidation—in line with
the known distinction in molecular events recruited under
memory consolidation and reconsolidation (Lee et al., 2004;
Veyrac et al., 2014). Notably, recent evidence derived from RNA
interference experiments in rats suggest that EGR1’s role in
memory reconsolidation rather reflects suppression of extinction
upon short memory recall and thus tilting of the balance
between activation of extinction or reconsolidation towards
the latter (Trent et al., 2015). Interestingly, EGR1 involvement
may not be restricted to memory encoding but is likely to be
expanded to neuronal encoding in a more global way. Indeed
EGR1 deletion in mice destabilizes the spatial representation
of a familiar environment in hippocampal CA1 place cells,
and impairs the long-term, but not the short-term stabilization
of a novel environment (Renaudineau et al., 2009). In the
same cells, EGR1 is up-regulated during a water maze
procedure regardless of the memory performance or even
in a non-learning version of the task, which suggests that
EGR1 up-regulation in place cells is activated each time the
animal enters an area related to the given place cells and
thus reflects spatial encoding rather than memory encoding
(Rapp et al., 1987; Guzowski et al., 2001; Shires and Aggleton,
2008; Laeremans et al., 2015), in line with the functional role
played by this cell population (O’Keefe and Dostrovsky, 1971).
Similarly, Carter et al. (2015) recently observed that exposure
to a water maze task increases EGR1 and c-Fos expression
through ERK1/2 activation and histone H3 phosphoacetylation
throughout the rat hippocampus regardless of the learning
component, although the effects were most pronounced in the
dentate gyrus.
Notably, while EGR1 regulation by neuronal activity and
plasticity underlying memory processes are well documented,
the exact transcriptional targets involved remain unclear. Under
this perspective, it is particularly interesting to consider another
IEG: Arg3.1 (also known as ARC). Indeed, EGR1 binds to
Arc promoter in vivo following synaptic activation and triggers
its transcription (Li et al., 2005). On a functional level, ARC
shares a lot of similarities with EGR1. Indeed, ARC is an
IEG up-regulated in neurons following synaptic activity, is
involved in the maintenance of LTP, and is required for
long-term memory consolidation but not short-term memory
formation or learning (Minatohara et al., 2015). Contrary
to EGR1, however, ARC mRNA and proteins can be found
in dendrites and post-synaptic locations (Kobayashi et al.,
2005) where it is believed to function by interacting with
other post-synaptic proteins. In particular, ARC interacts with
endophilin and dynamin to enhance endocytosis of α-amino-3-
hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors,
but also interacts with the actin cytoskeleton in dendritic spines
where it is required for cofilin phosphorylation and local F-actin
expansion (Chowdhury et al., 2006; Bramham et al., 2008).
As both processes are critical underpinning of major synaptic
plasticity events such as LTP, ARC-mediated reorganization
of actin cytoskeleton and synaptic architecture represents a
very promising candidate in mediating EGR1’s critical role in
synaptic plasticity and related behavioral outcomes such as
memory consolidation. It is important to note, however, that
ARC can also be regulated independently of EGR1, as observed
following intra-hippocampal brain-derived neurotrophic factor
infusion in rats (Ying et al., 2002), which, in addition to
illustrating the diversity in ARC regulation, further illustrates
the specificity in EGR1 recruitment underlying neuronal and
synaptic plasticity.
Interestingly, recent genome-wide investigations of
EGR1 transcriptional targets point towards a widespread
regulation of genes associated with similar dynamics critical
in regulating synaptic plasticity. Indeed, a multitude of genes
related to vesicular transport and neurotransmitter release,
clathrin-dependent endocytosis (involved in post-synaptic
receptor internalization), or actin cytoskeleton, are commonly
observed as direct EGR1 targets (ENCODE Project Consortium,
2012; Koldamova et al., 2014; Duclot and Kabbaj, 2015),
suggesting that besides ARC, many other EGR1 targets related
to these processes may be involved in the regulation of
synaptic activity by EGR1. In this context, it is particularly
interesting to note that EGR1 was recently described as
recruited to the postsynaptic density 95 (PSD-95) gene promoter
in response to NMDA receptor activation in hippocampal
primary neurons, leading to its repression (Qin et al., 2015).
As a result, EGR1 knockdown in rat hippocampal neurons
blocks NMDA receptors-induced PSD-95 down-regulation and
AMPA receptor endocytosis, while its overexpression has the
opposite effects (Qin et al., 2015). Similarly, the observation
that EGR1 controls the expression of genes related to protein
translation and ubiquitin-dependent degradation (James et al.,
2005, 2006; Baumgärtel et al., 2009) indicates that EGR1 can
coordinate a complex transcriptional program leading to
a synaptic reorganization at multiple levels that promotes
stabilization of the synapse, which would be in line with
the repeated involvement of this IEG in encoding synaptic
information.
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EGR1 ROLE IN PATHOLOGICAL STATES
As described above, EGR1 is regulated by a wide variety of
environmental stimuli and can regulate a large transcriptional
program related to critical processes underlying synaptic
plasticity and encoding of information. As a result,
EGR1 represents a key factor both in integrating perception of
the environment and in shaping an appropriate response. In this
context, it is therefore not surprising to find EGR1 associated
with neuropsychiatric illnesses in which neuronal plasticity and
activity is altered or dysfunctional. In the sub-sections below, we
will thus focus on some of the main neuropsychiatric disorders
in which EGR1 has been implicated.
Response to Stress
Despite their high prevalence (Kessler et al., 2012), stress-related
mood disorders such as anxiety and depression still remain
elusive in their exact etiology. Nevertheless, repeated exposure
to stressful experiences is now established to represent one of the
main risk factors for their development. As a result, a multitude
of animal models for depression and anxiety disorders relying
on the repeated exposure to stress of different nature have been
developed (Czéh et al., 2016). In this context, it is important to
first better understand EGR1’s regulation and role in response to
stress and in such animal models.
In accordance with its activation by neuronal activity,
EGR1’s regulation following exposure to stress is variable
depending on the nature and duration of the stress. An acute
physical stressor, such as restraint, immobilization, or forced
swim, leads to increase in Egr1 mRNA levels throughout
the brain including neocortical areas, hippocampus, lateral
septum, caudate putamen, nucleus accumbens, amygdala, and
paraventricular nucleus (PVN) of the hypothalamus (Schreiber
et al., 1991; Melia et al., 1994; Watanabe et al., 1994; Cullinan
et al., 1995; Olsson et al., 1997; Knapska and Kaczmarek, 2004;
Kozlovsky et al., 2009). Despite such a strong response to an
acute stress, repetition of the same stress blunts the stress-
induced EGR1 response, as observed in the PVN, hippocampus,
or cortical regions (Melia et al., 1994; Watanabe et al., 1994;
Girotti et al., 2006), and denotes a physiological habituation
to homotypic exposures to physical stressors. Despite this
habituation, however, exposure to a novel stress (shaking
stress vs. restraint stress) still leads to a full increase in
Egr1 mRNA levels in the PVN (Watanabe et al., 1994),
which thus indicates that habituation to the stressor is stress-
specific. Nevertheless, one study investigating the effects of
immobilization stress on IEGs expression in the PVN found
that whereas c-Fos and EGR1, among others, are up-regulated
upon acute immobilization, repetition of this stress for 6 days
suppresses such response for c-Fos, but not for EGR1 (Umemoto
et al., 1994, 1997). Furthermore, as chronic treatment with
high concentration of glucocorticoids (corticosterone) mimics
the effects of repeated stress exposure, the authors concluded
that glucocorticoids mediate the habituation of IEGs in the
PVN to repeated stress exposure while EGR1 was resistant
to such effect (Umemoto et al., 1997). As EGR1 is a reliable
marker of neuronal activity, these findings can be seen as
illustrations of the importance of the nature and intensity of
the stress on the neuronal and transcriptional response and
habituation upon repeated exposure. Interestingly, although
outside of the central nervous system, a recent genome-wide
investigation in the rat adrenal medulla of the evolution of genes
whose regulation is correlated with EGR1 following one or six
exposures to immobilization stress revealed a distinct profile of
interactions across time. Indeed, while EGR1 is up-regulated in
the rat medulla following both acute (1×) and repeated (6×)
exposure to the immobilization stress (Liu et al., 2008), its gene
interaction network differed between the two stress conditions,
indicating that EGR1 has different targets and functions between
acute and repeated exposure to an immobilization stress
(Papanikolaou et al., 2014). Altogether, stress is a major trigger
for EGR1 induction in the central nervous system. Nevertheless,
this activation mostly reflects the pattern of neuronal activity
in response to various stressors and, as a result, varies with
the nature, duration and intensity of the stress. This point is
particularly well illustrated by the positive correlation observed
between the magnitude of HPA axis activity, as measured
by plasma adrenocorticotropic hormone (ACTH) levels, and
Egr1 mRNA levels in the PVN—an intrinsic component of
the hypothalamic-pituitary-adrenals (HPA) axis—but not in the
hippocampus or cortical regions for which EGR1 signal was
more related to the exploration of the environment (Pace et al.,
2005).
Notably, in addition to being regulated by exposure to
stressful experiences, evidence indicates that EGR1 is a critical
factor in encoding the behavioral enduring effects of stress.
Indeed, acute exposure to forced swim stress or activation of
the glucocorticoid receptor (GR) up-regulates EGR1 expression
in the rat or mouse hippocampus, which mediates stress-related
fear memories (Revest et al., 2005, 2010; Saunderson et al., 2016).
Interestingly, such stress-induced EGR1 up-regulation depends
on the methylation status of its promoter (Saunderson et al.,
2016) and results in an increase in the expression and activation
of MAPK pathway-associated proteins (Revest et al., 2005)
as well as the synaptic plasticity-associated protein synapsin-I
(Revest et al., 2010). Combined with the blockade of stress-
related fear memory or GR-induced synapsin-I expression in
these paradigms by synapsin-I or EGR1 knockdown, respectively,
these data support a model in which EGR1 expression in the
rodent hippocampus is highly regulated by stress exposure, and
in turn controls synapsin-I expression to influence the synaptic
plasticity underlying the consolidation of stress-related memory
(Revest et al., 2010).
Stress-Related Mood Disorders and
Schizophrenia
Such variability in EGR1 response depending on the nature of
the stress is also particularly important in understanding the
link between EGR1 and the behavioral outcome of stress. As a
result, in postmortem tissue from patients suffering from major
depressive disorder, in which stress is a major risk factor (Czéh
et al., 2016), EGR1 levels in the prefrontal cortex are lower
when compared to healthy controls (Covington et al., 2010).
Notably, such reduction was observed in both unmedicated
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and medicated subjects not responding to treatment and thus
suggests that EGR1 levels in the mPFC are directly associated
with a depressive phenotype and could be seen as a marker
or mediator of positive response to antidepressant treatment
(Covington et al., 2010). In light of the tight link between
EGR1 expression and neuronal plasticity, the down-regulation
of EGR1 in the PFC of depressed patients is particularly
interesting and could represent one of the substrates for
the anatomical and functional alterations observed in major
depressive disorders in this brain area (Krishnan and Nestler,
2008; Koenigs and Grafman, 2009; Lefaucheur et al., 2017).
In this context, a similar dysregulation of EGR1 expression is
observed in other neuropsychiatric disorder characterized by
functional alterations in PFC activity such as schizophrenia,
where Egr1 mRNA levels are also found down-regulated in the
dorsolateral prefrontal cortex (Yamada et al., 2007; Kimoto et al.,
2014). Interestingly, EGR1 levels in the PFC of schizophrenia
patients are positively correlated with the mRNA levels for the
glutamic acid decarboxylase 1 (GAD1), whose down-regulation
is a robust molecular feature of schizophrenia subjects (Pérez-
Santiago et al., 2012; Kimoto et al., 2014). Notably, although
other IEGs such as c-Fos, c-jun, or EGR2 are also altered
in schizophrenia, their expression levels are not correlated
with GAD1 mRNA levels (Kimoto et al., 2014), which thus
supports a specific role for EGR1 in GAD1 regulation and
highlights its function as an important factor in the altered
cortical GABA synthesis and cognitive functions observed
in this neuropsychiatric disorder. Finally, in the search for
schizophrenia biomarkers in peripheral tissues, EGR1 levels
in whole blood samples was associated with schizophrenic
symptoms such as high delusional states (Kurian et al., 2011).
Similarly, EGR1 was among six genes identified as up-regulated
in fibroblasts from schizophrenic patients, and the only one
confirmed in peripheral blood cells as well (Cattane et al., 2015).
Although this regulation is opposite to the down-regulation
observed in the dorsolateral prefrontal cortex of schizophrenia
patients (Kimoto et al., 2014), the up-regulation of EGR1 in
blood cells was specific for schizophrenia when compared to
major depressive disorder or bipolar disorder (Cattane et al.,
2015), which confers EGR1 a particularly promising biomarker
potential in a clinical environment. Altogether, these findings
support a role for EGR1 in both the etiology and therapeutic
interventions in schizophrenia.
In line with these clinical observations, Egr1 mRNA levels are
generally found down-regulated in specific brain areas in animal
models inducing depressive- and anxiety-like states. For instance,
the exposure of male mice to 14 days of chronic unpredictable
stress leads to reduced levels of Egr1 mRNA in the hippocampus
associated with cognitive impairments in a water maze learning,
novel object recognition and location tasks, CA1 basal dendrites
atrophy, and altered ERK1/2 phosphorylation (Xu et al., 2015).
Similarly, while an acute social defeat stress increases Egr1
mRNA in the male mouse hippocampus (Rusconi et al., 2016),
reduced Egr1 mRNA levels in the mouse mPFC are found
following repeated social defeat (Covington et al., 2010), a
well-established animal model for depressive- and anxiety-like
states (Hollis and Kabbaj, 2014). Notably, EGR1 expression
is also reduced in the prefrontal cortex of human depressed
subjects unmedicated or not responding to treatment, which thus
suggests that EGR1 levels in the mPFC are directly associated
with a depressive phenotype and could be seen as marker or
a mediator of positive response to antidepressant treatment
(Covington et al., 2010). Accordingly, reduced Egr1 mRNA levels
in the brain are commonly observed in another well-established
animal model of depressive-like state, social isolation. Indeed,
reduced EGR1 expression is observed in the PVN, mPFC, HPC,
or extended amygdala of rats, mice and prairie voles following
social isolation (Northcutt and Lonstein, 2009; Matsumoto et al.,
2012; Hodges et al., 2014; Okada et al., 2014, 2015; Hodges and
McCormick, 2015; Ieraci et al., 2016).
Despite the strong association of EGR1 expression levels
with depression- and anxiety-like behaviors described above, the
evidence for a functional link was obtained from the behavioral
phenotype of EGR1-KO mice, which present with lower anxiety
levels reflected by higher exploratory behavior in the open arms
of an elevated plus maze (Ko et al., 2005). Since then, the role
of EGR1 in regulating anxiety has been further described and
targeted to the mPFC, although other structures such as the
amygdala or ventral HPC are likely to contribute. In particular,
we demonstrated that EGR1 expression levels in the rat mPFC
control the social interaction behavior, an indicator of social
anxiety, and was sufficient to explain sex differences in social
interactions observed in Sprague-Dawley rats (Stack et al., 2010).
Indeed, the lower levels of social interaction displayed by females
when compared to males are paralleled by lower levels of
EGR1 mRNA and proteins in the mPFC. Furthermore, antisense-
mediated EGR1 knockdown in the mPFC of males reduced their
social interaction levels to those of females (Stack et al., 2010).
Conversely, viral-mediated EGR1 overexpression in the mPFC
prevents deficits in social interactions induced castration in male
rats (Dossat et al., 2017). Similarly, the intracerebroventricular
injection of locked-nucleic acid-modified antisense nucleotide
knocking down miR-124—which inhibits EGR1—reverses the
social interactions impairments in EPAC-KO mice (Yang et al.,
2012). Notably, it is particularly interesting to note that
partial changes in EGR1 protein levels seen in the studies
described above, especially in the mPFC, are sufficient to
substantially alter complex behaviors such as social interactions.
In addition to indicating that variations in EGR1 levels are critical
in determining anxiety levels, this suggests that endogenous
variations in EGR1 protein levels in the mPFC such as those
occurring throughout the female estrous cycle (Duclot and
Kabbaj, 2015) are likely to be associated with variations in
anxiety-related behaviors. Accordingly, estrous cycle-dependent
variations in anxiety-like behaviors are reported in female
rodents (Donner and Lowry, 2013; Barth et al., 2015).
In addition to its association with the development of
anxiety- and depression-like states, EGR1 is actively regulated
by several classes of antidepressant treatments throughout the
brain. While behavioral antidepressant effects are typically
observed following chronic, but not acute, treatment, it
is surprising to find an up-regulation of EGR1 in the
rat hippocampus following a single dose of the tricyclic
antidepressant desipramine (Dahmen et al., 1997), or in
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the rat amygdala following an acute dose of fluoxetine,
imipramine, mirtazapine, or lithium chloride (Slattery et al.,
2005). Nevertheless, no effects were observed in other brain
regions analyzed, suggesting that this effect was relatively
constrained (Slattery et al., 2005). Following chronic treatment
regimen, the effect is more robust as EGR1 is up-regulated
following a wide variety of antidepressant treatments—ranging
from the classical antidepressants imipramine and fluoxetine,
to electroconvulsive seizures (ECS)—and in multiple key
brain areas for antidepressant effects such as the mPFC and
hippocampus (Morinobu et al., 1995, 1997; Bjartmar et al.,
2000). Interestingly, this effect may not be restricted to
neurons as imipramine application on cultured rat astrocytes
up-regulates EGR1 expression in a MAPK-dependent manner,
which then binds to the glial cell line-derived neurotrophic
factor (gdnf ) gene promoter and activates its expression (Kim
et al., 2011). Moreover, while these effects were observed in
unstressed systems, which could thus be considered at baseline,
experimental interventions exerting an antidepressant-like effect,
such as environmental enrichment, FGF2, or fluoxetine, have
also been reported to reverse or protect from induction of
anxiety- and depressive-like states in multiple models (Monsey
et al., 2014; Novaes et al., 2017; Salmaso et al., 2016). Although
causality still remains to be clearly established, the up-regulation
of EGR1 following antidepressant treatment thus emerges as
a key feature of antidepressant response. This is particularly
interesting in light of the reduced EGR1 expression found
in the frontal cortex of depressed patients who remained
symptomatic despite being medicated, as this further suggests
that EGR1 up-regulation could represent a reliable marker
for positive therapeutic response to antidepressants (Covington
et al., 2010).
Interestingly, despite its low expression levels early in the
development, EGR1 has been identified as an important mediator
of the effects of early-life experience through its transcriptional
control of the gr gene. For instance, the levels of maternal care
received by rat pups during the first week of life determines
their neuroendocrine response to stress later in adulthood,
through DNA methylation at the hippocampal gr promoter
located on an EGR1 binding site (Weaver, 2007). As evidence
suggests that maternal care triggers serotonin release in the
hippocampus, it is particularly interesting that EGR1 knockdown
by RNA interference prevents serotonin-induced increase in GR
expression in cultured rat hippocampal neurons (Weaver et al.,
2007), which thus suggests that the extent of maternal care
received by the pup during the first week of life will influence
EGR1 binding to the gr promoter, which will in turn determine
GR expression in a long-lasting manner through epigenetic
mechanisms (Weaver, 2007). Notably, children exposed to
physical maltreatment—a known risk factor for the development
of mood-related alterations in adulthood (Shackman et al.,
2007; Shackman and Pollak, 2014)—present with greater DNA
methylation of the gr promoter, including at the EGR1 binding
site (Romens et al., 2015), indicating that such EGR1 control
of GR expression by maternal care could also be observed in
humans. Moreover, other early-life stressful experiences have
similarly been reported to impact EGR1 expression. Maternal
separation of C57Bl/6 mice from postnatal day 14–16, for
instance, induces a rapid increase in EGR1 expression and its
target ARC in the hippocampus through histone acetylation
at their respective promoter (Xie et al., 2013). Although
causality remains to be determined, these changes are associated
with greater dendritic complexity and spine number in the
hippocampal CA3 area (Xie et al., 2013), suggesting that early-life
experiences can affect neuronal architecture and organization
through EGR1. The timing of such manipulation is critical,
however, as maternal separation in the same C56Bl/6 strain
from postnatal day 2–15 leads to a marked reduction in
EGR1 expression in the forebrain neocortex (Navailles et al.,
2010).
In addition to shape response to stress later in adulthood,
early-life experiences can also impact the development of
neuropsychiatric disorders such as schizophrenia. Indeed,
adult rats having received high levels of maternal care
present with higher GAD1 mRNA hippocampal levels than
individuals raised by dams providing low levels of maternal
care (Zhang et al., 2010). Notably, this regulation is mediated
by EGR1 binding, along with higher H3K9 acetylation and
lower DNA methylation, at the gad1 promoter (Zhang et al.,
2010), and thus directly implicates EGR1 in the regulation of
GAD1 expression in the brain, which is of particular interest
in the context of neuropsychiatric illness in light of the positive
correlation between GAD1 and EGR1 expression levels in
schizophrenia patients (Kimoto et al., 2014). While the molecular
underpinnings of EGR1 alterations in schizophrenia remain
unknown, knockdown in cultured hippocampal GABA neurons
of the histone deacetylase 1 (HDAC1) and its co-repressor
DAXX, whose expressions are also altered in schizophrenia,
results in increased GAD1 and Egr1 mRNA levels, which
opens the possibility for an HDAC1/DAXX-mediated repression
of EGR1 expression leading to GAD1 inhibition (Subburaju
et al., 2016). Furthermore, beyond its etiology, EGR1 is also
associated with response to antipsychotic drugs (MacGibbon
et al., 1994; Robbins et al., 2008; Bruins Slot et al., 2009; Wheeler
et al., 2014; de Bartolomeis et al., 2015), or the psychomimetic
phencyclidine in rats (Tamminga et al., 1995; Näkki et al.,
1996).
Altogether, the above experimental evidence highlights the
important role played by EGR1 in mediating or modulating the
stress response and the development of various stress-related
disorders. The upstream regulators involved, however, remain
unclear and it thus becomes interesting to further consider
the link between glucocorticoids released following chronic
stress, and EGR1 expression in the central nervous system.
Indeed, while EGR1 is a direct regulator of gr transcription,
activation of GR leads to EGR1 up-regulation in the mouse
and rat hippocampus through intracellular signaling pathways
involving MAPK (Revest et al., 2005, 2010) or the serum and
glucocorticoid regulated kinase 1 (SGK1; Tyan et al., 2008).
Notably, the regulation of EGR1 expression by SGK1 involves
well-defined mechanisms of Egr1 transcriptional regulation via
the activation by phosphorylation of SRF and CREB, and has
been linked to spatial memory formation in rats (Tyan et al.,
2008). As its expression in the rodent hippocampus and mPFC
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rodents is strongly regulated by acute (Bohacek et al., 2015;
Mifsud and Reul, 2016) or chronic stress (Anacker et al., 2013;
Miyata et al., 2015; Skupio et al., 2015; Cattaneo and Riva, 2016;
Wei et al., 2016), SGK1 emerges as a particularly interesting
candidate in mediating EGR1 regulations in response to various
stress paradigms. In this context, it is particularly interesting
to note that SGK1 expression levels are down-regulated
in the PFC of post-traumatic stress disorder patients—or
increased in the peripheral blood of unmedicated depressed
patients (Anacker et al., 2013)—and that SGK1 inhibition in
the rat mPFC induces depressive-like behaviors in rodents
associated with abnormal dendritic spine morphology and
synaptic dysfunction (Licznerski et al., 2015). Altogether, these
experimental observations delineate a hypothetical working
model in which glucocorticoids release following chronic stress
exposure alters SGK1 expression in key brain areas including
the hippocampus and mPFC, which in turns regulates Egr1
transcription through activation of SRF and CREB transcription
factors. Although the requirement of EGR1 in SGK1’s effects on
neuronal plasticity remains to be determined, EGR1 could in turn
orchestrate, through its wide array of targets, the neuronal and
synaptic plasticity events underlying the long-term behavioral
effects of stress that influence the development of stress-related
disorders such as depression or PTSD.
Drug Reward, Withdrawal and Relapse
Exposure to substance of abuse is a powerful environmental
stimulus that triggers a strong neuronal response throughout the
brain, but mainly targeting the mesolimbic dopaminergic system,
and bears the ability to reorganize existing neuronal connections
in a long-lasting manner. IEGs such as EGR1 have thus been
repeatedly associated with the neuronal response to large number
of compounds with rewarding or addictive properties. EGR1’s
involvement in response to cocaine, for instance, are now
relatively well-described and reviewed elsewhere (Veyrac et al.,
2014). We will thus focus the following section on two distinct
classes with rewarding properties.
Opiates, for instance, are known triggers for EGR1 expression
in various brain areas. In particular, an acute heroin injection
up-regulates Egr1 mRNA levels in the core and shell of the
nucleus accumbens, the dorsal striatum, and the cingulate cortex
of C57Bl6 mice (El Rawas et al., 2009). Similarly, increased
EGR1 expression levels are observed in the extended amygdala,
dorsal striatum, nucleus accumbens shell, and cingulate cortex
following an acute morphine injection (Hamlin et al., 2007;
Ziółkowska et al., 2012, 2015). Notably, the latter is observed
4 h and 6 h following injection, which suggests that in this
context, EGR1 up-regulation is part of a second wave of gene
regulations, and is not associated with the rapid hyperlocomotor
effects of morphine (Ziółkowska et al., 2015). They do suggest,
however, that EGR1 can be involved in neuroadaptations
underlying long-lasting effects of morphine exposure, such
as withdrawal and relapse. Accordingly, naloxone-induced
morphine withdrawal in rats induces an EGR1 up-regulation
in the cerebral cortex, hippocampus, thalamus, cerebellum, and
brainstem 60 min following the withdrawal (Beckmann et al.,
1995). Similarly, EGR1 and its target ARC are up-regulated
in the rat dentate gyrus upon morphine-withdrawal memory
retrieval which, in light of its established role of in contextual
memory reconsolidation in the hippocampus (Lee et al., 2004),
suggests that EGR1 could be involved in the synaptic plasticity
events underlying reconsolidation of the morphine withdrawal-
context (García-Pérez et al., 2016). Under a similar perspective,
EGR1 expression is increased in the rat basolateral but not
central amygdala during reconsolidation of withdrawal memory,
whereas its down-regulation by antisense oligodeoxynucleotides
within the basolateral amygdala reduces the withdrawal memory-
mediated suppression of heroin seeking (Hellemans et al., 2006),
thereby indicating a functional role for EGR1 in encoding heroin
seeking in the amygdala. In line with the tight interplay between
the amygdala and the mPFC during cue-associated memory
reactivation, extinction, or reconsolidation, Egr1 mRNA levels
are also found up-regulated in the rat mPFC following 14 or
30 days of heroin-seeking incubation (Kuntz et al., 2008; Kuntz-
Melcavage et al., 2009; Fanous et al., 2013), which thus strengthen
further the importance of EGR1 in regulating multiple aspects of
opiates dependance.
Similar to opiates, alcohol consumption triggers a marked
EGR1 response throughout the brain. In adult rats and mice,
acute ethanol exposure leads to increased EGR1 expression
in the mPFC, central amygdala, medial amygdala, supraoptic
nucleus, PBN, lateral part of the caudate putamen, prelimbic
and infralimbic cortices, orbitofrontal cortex, hippocampus and
nucleus accumbens (Thiriet et al., 2000; Faria et al., 2008;
Hansson et al., 2008; Lindholm et al., 2008; Liu and Crews, 2015).
Repeated exposure for 15 days, however, or chronic intermittent
exposure, reduces Egr1 mRNA levels in the mPFC, hippocampus,
and nucleus accumbens (Repunte-Canonigo et al., 2007; Faria
et al., 2008), which thus indicates that EGR1’s regulation by
ethanol depends on the nature and duration of the exposure.
Moreover, this dynamic regulation of EGR1 by ethanol is further
illustrated upon withdrawal. Indeed, Egr1 mRNA and protein
levels are up-regulated in the cerebral cortex, olfactory bulb,
inferior colliculus, brainstem, and hippocampus of ethanol-
dependent rats at 12 h and 15–24 h, respectively, following
withdrawal (Matsumoto et al., 1993), a process associated
with increased EGR1 DNA binding activities in the cerebral
cortex from 16 h to 72 h following withdrawal (Beckmann
et al., 1997). Interestingly, while withdrawal-induced anxiety-like
behaviors emerge within the same period, between 8 h and
17 h following withdrawal (Matsumoto et al., 1993), withdrawal-
induced anxiety-like behaviors in mice, which rise on the 1st
day of withdrawal and last up to 21 days later, are positively
correlated with the increase in EGR1-positive cells in the central
amygdala and bed nucleus of the stria terminalis (Lee et al.,
2015), which thus link the increase in EGR1 expression in the
amygdala to the development of anxiety-like symptoms upon
ethanol withdrawal.
CONCLUSIONS
In this review article, we summarized and discussed the
regulations and functions of the IEG EGR1 in the central
nervous system relevant to neuropsychiatric disorders. Situated
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downstream of general signaling pathways activated by neuronal
activity, EGR1 has been found regulated by a wide variety
of environmental events that position EGR1 as a critical
integrator and mediator of environmental influences on
neuronal activity. Furthermore, due to its very large range of
potential transcriptional targets identified so far, the reach of
EGR1’s functions in neurons continues to expand. In particular,
without considering eventual indirect effectors, EGR1 can alter
the expression of genes related to every level of synaptic plasticity,
from vesicular transport and release of neurotransmitters, to
synaptic architecture, endocytosis, and protein degradation
(Figure 2). Notably, in line with its sex- and estrous cycle-
dependent expression in the rat mPFC, it is important to
consider that this control of synaptic plasticity by EGR1 is
likely to substantially vary between sexes in an estrous cycle-
dependent manner. Despite such wide array of synaptic
plasticity-related potential targets and its well-known association
with neuronal activity. however, the current knowledge of the
precise mechanisms by which EGR1 influences synaptic and
neuronal plasticity, as well as the direct targets involved, remains
paradoxically unclear and requires to be clearly described and
validated in vivo. Nevertheless, EGR1 is tightly associated to
neuronal activity throughout the brain and can thus be used
as a reliable tool for mapping neuronal activity in response
to a given environmental event. In this context, it is possible
to consider that a substantial amount of EGR1’s regulations
described in this review simply reflect neuronal responses
in a given structure to a given behavioral stimulation. It
is important to note, however, that EGR1 governs specific
neuronal processes, which can be reflected, for instance, by its
specific involvement in the maintenance but not induction of
LTP, or, under appropriate conditions, memory reconsolidation
but not acquisition, for instance. In line with its crucial
role in shaping neuronal response, EGR1 is associated with
the etiology and treatment of most common neuropsychiatric
disorders such as major depressive disorder, anxiety disorders,
schizophrenia, or addiction. Therefore, despite its widespread
mode of regulation, EGR1 functions in the central nervous
system are complex and represent a valuable candidate for
investigating gene× environment interactions.
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